Re-audit in Healthcare: Effective Timing and Strategy

Why this topic matters

Effective re-audit is essential for several reasons. Firstly, it verifies that implemented changes have indeed led to the desired improvements in patient care, processes, or outcomes. Without re-audit, an audit cycle is incomplete, making it difficult to attest to the success of an intervention. Secondly, re-audit provides evidence of sustained change, moving beyond initial positive results to demonstrate that new practices are embedded and maintained over time. This is particularly important for regulatory bodies like the CQC and for demonstrating effective governance.

Moreover, re-audit is integral to continuous quality improvement (CQI). It allows teams to identify if initial improvements have plateaued or if new issues have emerged, prompting further cycles of audit and improvement. For clinicians, participating in and understanding re-audit processes is a core competency, often required for revalidation and demonstrating engagement in quality improvement activities.

Practical explanation: What influences re-audit timing?

There is no 'one-size-fits-all' answer to how long you should wait before re-audit. The optimal timing is influenced by several key factors:

1. Nature of the intervention

• Complexity of change: Simple changes (e.g., updating a proforma) might show rapid impact, allowing for an earlier re-audit (e.g., 3-6 months). More complex or systemic changes (e.g., new ward rounds structure, multidisciplinary team pathway changes) may take longer to embed and show measurable effects, requiring a longer interval (e.g., 6-12 months or more).
• Impact on patient outcomes: If the intervention directly impacts critical patient safety or high-volume processes, it might warrant closer monitoring and a slightly earlier re-audit once changes are established.

2. Time required for change to embed

For any new practice or process to become standard, it needs time to be adopted by all relevant staff, for initial teething problems to be resolved, and for staff confidence and competence to grow. Re-auditing too soon may capture transient improvements or highlight lack of compliance due to incomplete embedding, rather than a true reflection of the intervention's long-term effectiveness.

3. Data collection cycle and availability

Consider the availability of data. If the audit criteria rely on data that accumulates slowly (e.g., 6-month mortality rates, annual incident reports), then naturally, the re-audit period must align with when sufficient new data will be available for meaningful comparison. Ensure your data collection period for re-audit is comparable to your baseline audit.

4. Organisational priorities and resources

Audit capacity, staff availability, and competing organisational priorities can all impact re-audit timing. While demonstrating improvement is crucial, practical constraints must be acknowledged. Sometimes, a phased approach to re-audit or focusing on key outcome measures initially can be pragmatic.

5. Type of audit

• Standard-based national audits: For many national audits (e.g., stroke, myocardial infarction), the re-audit cycle is often dictated by the national body (e.g., annual data submission).
• Local audits vs. QI projects: A 'pure' audit cycle typically involves a discrete re-audit. Quality Improvement (QI) projects, however, often incorporate continuous measurement and iterative 'Plan-Do-Study-Act' (PDSA) cycles, where re-measurement is more frequent and integrated into the improvement process itself. While not strictly 're-audit', these cycles serve a similar purpose of assessing impact.

Common pitfalls

• Re-auditing too early: This is perhaps the most common mistake. It can lead to disappointing results, misinterpretations of the intervention's effectiveness, and wasted effort. It may reflect incomplete embedding of changes rather than a failed intervention.
• Never re-auditing: An uncompleted audit cycle fails to demonstrate improvement, wasting the initial effort and missing opportunities for sustained change and learning.
• Inconsistent methodology: The re-audit methodology (e.g., sample size, data collection tools, criteria) must be consistent with the initial audit to allow for valid comparison. Deviations can render results incomparable.
• Lack of baseline comparison: Re-audit data is only meaningful when compared to the original baseline audit. Ensure baseline data is readily accessible.
• Ignoring 'negative' re-audit results: A re-audit showing no improvement or even deterioration is not a failure of the audit, but an opportunity to learn. It indicates the need to re-evaluate the intervention, identify new barriers, or consider alternative approaches.

Step-by-step approach to planning your re-audit

1. Review the initial audit findings and implemented changes: Clearly articulate what changes were made based on the initial audit findings.
2. Define your goal for the re-audit: What specific improvement or sustained practice are you aiming to confirm?
3. Establish clear, measurable re-audit criteria: These should ideally be the same as the initial audit criteria to allow for direct comparison.
4. Consider the embedding period: Based on the complexity of the intervention and expected time for staff adoption, estimate a realistic interval for re-audit. A common timeframe for many local audits is 6 to 12 months post-intervention implementation, but this can vary significantly.
5. Plan your data collection: Identify the data source(s), sample size (aim for comparable with baseline), and data collection tool. Ensure staff are aware of the re-audit.
6. Secure resources: Ensure you have the time and personnel to conduct the re-audit effectively.
7. Conduct the re-audit: Collect new data adhering to the defined methodology.
8. Analyse and compare results: Directly compare the re-audit data with your baseline audit data. Use appropriate statistical methods where applicable.
9. Disseminate findings and determine next steps: Present the results to relevant stakeholders. If improvements are sustained, celebrate success and consider wider implementation. If not, analyse why and plan further interventions or another audit cycle.

Example in clinical practice

A junior doctor team conducted an audit on venous thromboembolism (VTE) prophylaxis documentation for medical inpatients. The initial audit showed 65% compliance with local guidelines. Following this, an educational session was delivered to junior doctors, new VTE proforma stickers were introduced in patient notes, and nursing staff were reminded about their role in checking documentation. The team planned to re-audit.

Given the multi-faceted intervention involving education and a new tool, and allowing time for new junior doctors to rotate through and adopt the new practice, the team decided to set a re-audit period of 8 months after the intervention was fully implemented. They used the same audit tool and sample size (100 consecutive medical admissions) to ensure comparability. The re-audit demonstrated 92% compliance, indicating a significant and sustained improvement. The results were disseminated to medical and nursing teams, and the local audit department, leading to a decision to incorporate the VTE proforma education into the Trust's induction programme for all new doctors.

How Lazomis can help

Lazomis provides structured tools that can significantly streamline the re-audit process. Our project management features allow you to easily define and track your original audit, log interventions, and schedule your re-audit. You can store your baseline data and re-audit methodology within the platform, ensuring consistency.

For data collection, Lazomis templates can be adapted for re-audit, simplifying data capture and ensuring adherence to your predefined criteria. Our analytical dashboards can then help you visualise and compare baseline versus re-audit data quickly, making it easier to identify and present the impact of your improvement efforts. This structured approach helps ensure your re-audit cycle is efficient, robust, and provides clear evidence of sustainable change.

This resource supports, but does not replace, clinical judgement. Local policy, formulary and specialist advice should be followed.